What does the latest Nature breakthrough in aromatic amine substitution mean for industrial xylidine chemistry?

What does the latest Nature breakthrough in aromatic amine substitution mean for industrial xylidine chemistry?
The new direct substitution chemistry bypassing classical diazotization could reshape how xylidine isomers are used in pharmaceutical intermediates. In practice, diazotization accounts for only about 1% of medicinal chemistry steps and even less in scale-up, mainly due to safety risks of diazo compounds. The value emerges when alternative routes are costly, such as in chiral amino acid transformations or when building multi-substituted aromatic rings. For xylidine isomers like 2,3-dimethylaniline, sourced from o-xylene via nitration and reduction, the Sandmeyer route remains dominant for making intermediates like medetomidine. The breakthrough may eventually offer safer, more efficient paths for functionalizing these amines, potentially reducing reliance on hazardous diazonium chemistry in commercial production.